Medical News

RSS

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

In the last month, Anthony Scalzo, M.D., professor of toxicology at Saint Louis University, has seen nearly 30 cases involving teenagers who were experiencing hallucinations, severe agitation, elevated heart rate and blood pressure, vomiting and, in some cases, tremors and seizures. All of these teens had smoked a dangerous, yet legal substance known as K2 or "fake weed."

3 Mar 2010

MSU risk assessment: Reliable method to assess lead-poisoning risk in children

As health departments across the United States seek a better way to determine which children should be tested for lead poisoning, a method created by Michigan State University scientists has proven to be more accurate and cost-effective than current strategies.

3 Mar 2010

Royal Philips Electronics, Microsoft collaborate to improve Philips Healthcare's efficiency and productivity

Royal Philips Electronics today announced collaboration with Microsoft Corp. to build on Philips Healthcare's foundation of healthcare informatics and advanced clinical decision support offerings that drive efficiency and effectiveness at the point of care.

From Philips Healthcare 3 Mar 2010

SCLL signs agreement to provide research and assay services in support of Agennix's talactoferrin program

Stem Cell Innovations announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line.

3 Mar 2010

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Study: Offspring of two parents with schizophrenia more likely to develop same illness

Offspring of two parents with schizophrenia or bipolar disorder appear more likely to develop the same illness or another psychiatric condition than those with only one parent with psychiatric illness, according to a report in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

3 Mar 2010

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program. EDP-239 has demonstrated picomolar potency against multiple genotypes of the virus and a preclinical pharmacokinetic profile amenable to once-a-day dosing.

3 Mar 2010

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

The Canadian Fertility and Andrology Society supports fully the provision of publicly funded in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment across Canada. Infertility has been defined by the World Health Organization as a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

China Nepstar Chain Drugstore declares US$0.28 dividend per ADS

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared a cash dividend of US$0.28 per American Depositary Share (ADS).

3 Mar 2010

China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2009.

3 Mar 2010

Physician experts to help provide perspective on many options for colorectal cancer screening

Recent reports of President Obama's CT colonography, or virtual colonoscopy, as a screening test for colorectal cancer and coverage by the Associated Press of an NIH State-of-the-Science conference heralding stool blood tests as an inexpensive alternative to colonoscopy may leave many consumers wondering which colorectal cancer test is best for them.

3 Mar 2010

PINC trial to test anti-malarial drug in women with DCIS

Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.

3 Mar 2010

UHSM uses Aruba Networks’ VBN solution to increase quality of antenatal services

Aruba Networks, Inc., a global leader in 802.11n wireless LANs and secure mobility solutions, today announced that the University Hospital of South Manchester NHS Foundation Trust in the United Kingdom is using Aruba’s Virtual Branch Networking (VBN) solution to increase the quality of antenatal services delivered to the local community.

3 Mar 2010

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Robotic surgical technology with its three-dimensional, high-definition view gives surgeons the sensation of touch, even as they operate from a remote console. A new study describes the phenomenon, called intersensory integration, and reports that surgical outcomes for prostate cancer surgery using minimally invasive robotic technology compare favorably with traditional invasive surgery.

3 Mar 2010

Harvard Professor urges medical community to use ultrasound for diagnosing acute female pelvic conditions

In a bold, eye-opening editorial in the March 2010 issue of the Journal of Ultrasound in Medicine, Harvard Professor, Beryl Benacerraf, MD, urges the medical community to use ultrasound instead of Computed Tomography (CT) as the first-line imaging test for better diagnosis capability in the evaluation of acute female pelvic and lower abdominal conditions.

3 Mar 2010

Solos Endoscopy signs agreement with ER for CE Mark Technical File development consulting services

Solos Endoscopy, Inc. is pleased to announce the Company has signed an agreement with Expert Resource (ER) to provide consulting services in support of the Company's CE Mark Technical File development. Before Solos can place the CE Marking on their medical devices and legally sell within the European Union (EU) and Canada, the Company must prepare a Technical File with evidence of compliance to the EU Medical Device Directive.

3 Mar 2010

Warren Buffet supports Senate bill, Franken and Ryan pushing their health reform ideas

CNBC interviewed billionaire investor Warren Buffett, who "called the nation's health care spending 'untenable,' comparing 'out of control' costs to a 'tapeworm eating at our economic body.' While he would support the current Senate health care reform bill if pressed, Buffett says he would prefer a 'Plan C' that would control costs by changing the financial incentives of the system" (Crippen, 3/1).

3 Mar 2010

Axiogenesis, Lonza Cologne announce global distribution agreement

Axiogenesis AG has entered into a worldwide, exclusive distribution agreement with Lonza Cologne AG effective 01 January 2010. The agreement includes Axiogenesis’s current product and service portfolio, including the industry standard Cor.At® mouse embryonic stem cell-derived cardiomyocytes.

3 Mar 2010

Medical News

Toxins in K2: Saint Louis University professor warns parents to lookout for warning signs

MSU risk assessment: Reliable method to assess lead-poisoning risk in children

Royal Philips Electronics, Microsoft collaborate to improve Philips Healthcare's efficiency and productivity

SCLL signs agreement to provide research and assay services in support of Agennix's talactoferrin program

China Medical Technologies reports revenues of US$25.2 million for third-quarter fiscal 2009

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Study: Offspring of two parents with schizophrenia more likely to develop same illness

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

CFAS supports the provision of publicly funded IVF and ICSI treatment across Canada

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

China Nepstar Chain Drugstore declares US$0.28 dividend per ADS

China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009

Physician experts to help provide perspective on many options for colorectal cancer screening

PINC trial to test anti-malarial drug in women with DCIS

UHSM uses Aruba Networks’ VBN solution to increase quality of antenatal services

Robotic surgery does not compromise clinical outcomes for prostate cancer surgery

Harvard Professor urges medical community to use ultrasound for diagnosing acute female pelvic conditions

Solos Endoscopy signs agreement with ER for CE Mark Technical File development consulting services

Warren Buffet supports Senate bill, Franken and Ryan pushing their health reform ideas

Axiogenesis, Lonza Cologne announce global distribution agreement

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News